Skip to main content

Advertisement

Log in

Variables related to utility in patients with ankylosing spondylitis

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

The objective of this study was to identify variables associated to the utility of the health states in patients with ankylosing spondylitis (AS). A cross-sectional study was performed in a tertiary care centre. AS patients (New York modified criteria) were included. Demographic and disease-related variables were collected. The social tariffs of the EuroQol-5D (EQ-5D) were used to obtain utility values. Univariate and multivariate regression analyses were used in order to identify variables associated with utility. Seventy patients, 52 male (74.3%), with age (mean ± SD) 43.7 ± 9.1 years and disease duration 10.8 ± 8.1 years, were included. The mean utility was 0.5625 ± 0.3364. In the univariate analysis, patient global assessment, Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Bath Ankylosing Spondylitis Functional Index (BASFI) had a good correlation with the EQ-5D values (Pearson’s product moment correlation coefficient r > 0.6) whereas physician global assessment, patient pain assessment, and cervical rotation had a moderate correlation with the EQ-5D (0.6 > r > 0.4). Patients with significant comorbidity had lower utility values (0.3563 ± 0.068) than those without it (0.6796 ± 0.041, p = 0.0001). In the multivariate analysis, BASFI and BASDAI kept an independent association with utility and they explained a 62% of the variance of the utility values. In this study, physical function and disease activity, two outcomes with good responsiveness to the treatment, were the main determinants of the utility of the health states in AS patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. van der Linden S, van der Heijde D (1998) Ankylosing spondylitis: clinical features. Rheum Dis Clin N Am 24:663–676

    Article  Google Scholar 

  2. Ward MM (1999) Health related quality of life in ankylosing spondylitis. A survey of 175 patientsArthritis Care Res 12:247–255

    CAS  Google Scholar 

  3. Ariza-Ariza R, Hernández-Cruz B, Navarro-Sarabia F (2003) Physical function and health related quality of life of Spanish patients with ankylosing spondylitis. Arthritis Rheum 49:483–487

    Article  PubMed  Google Scholar 

  4. Ozgul A, Peker F, Taskaynatan MA, Tan AK, Dincer K, Kalyon TA (2006) Effects on ankylosing spondylitis on health-related quality of life and different aspects of social life in young patients. Clin Rheumatol 25:168–174

    Article  PubMed  Google Scholar 

  5. Chorus AM, Miedema HS, Boonen A, Van der Linden S (2003) Quality of life and work in patients with rheumatoid arthritis and ankylosing spondylitis of working age. Ann Rheum Dis 62:1178–1184

    Article  PubMed  CAS  Google Scholar 

  6. Doward LC, Spoorenberg A, Cook SA et al (2003) Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis. Ann Rheum Dis 62:20–26

    Article  PubMed  CAS  Google Scholar 

  7. Haywood KL, Garratt A, Dziedzic K, Dawes PT (2003) Patient centered assessment of ankylosing spondylitis-specific health related quality of life: evaluation of the Patient Generated Index. J Rheumatol 30:764–773

    PubMed  Google Scholar 

  8. Ware JE, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36) I. Conceptual framework and item selection. Med Care 30:473–481

    Article  PubMed  Google Scholar 

  9. Jenkinson C, Layte R (1997) Development and testing of the UK SF-12 (short form health survey). J Health Serv Res Policy 2:14–18

    PubMed  CAS  Google Scholar 

  10. Bakker C, van der Linden S (1995) Health related utility measurement: an introduction. J Rheumatol 22:1197–1199

    PubMed  CAS  Google Scholar 

  11. Guillemin F (1999) The value of utility: assumptions underlying preferences and quality adjusted life years. J Rheumatol 26:1861–1863

    PubMed  CAS  Google Scholar 

  12. Boonen A, Patel V, Traina S, Chiou CF, Maetzel A, Tsuji W (2008) Rapid and sustained improvement and health-related quality of life and utility for 72 weeks in patients with ankylosing spondylitis receiving etanercept. J Rheumatol 35:662–667

    PubMed  CAS  Google Scholar 

  13. Boonen A, van der Heijde D, Landewé R, van Tubergen A, Mielants H, Dougados M, van der Linden S (2007) How do the EQ-5D, SF-6D, and the well-being rating scale compare in patients with ankylosing spondylitis. Ann Rheum Dis 66:771–777

    Article  PubMed  Google Scholar 

  14. Verstappen SM, Jacobs JW, van der Heijde DM, van der Linden S, Verhoef CM, Bijlsma JW, Boonen A (2007) Utility and direct costs: ankylosing spondylitis compared with rheumatoid arthritis. Ann Rheum Dis 66:727–731

    Article  PubMed  CAS  Google Scholar 

  15. Kobelt G, Andlin-Sobocki P, Maksymowych WP (2006) Cost and quality of life of patients with ankylosing spondylitis in Canada. J Rheumatol 33:289–295

    PubMed  Google Scholar 

  16. Boonen A, van der Heijde D, Severens JL, Boendermaker A, Landewé R, Braun J et al (2006) Markov model into the cost-utility over five years of etanercept and infliximab compared with usual care in patients with active ankylosing spondylitis. Ann Rheum Dis 65:201–208

    Article  PubMed  CAS  Google Scholar 

  17. Rutten-van Molken MP, Bakker CH, van Doorslaer EK, van der Linden S (1995) Methodological issues of patient utility measurement. Experience of two clinical trials. Med Care 33:922–937

    Article  PubMed  CAS  Google Scholar 

  18. Bakker C, Rutten-van Molken M, Hidding A, van Doorslaer E, Bennet K, van der Linden S (1994) Patient utilities in ankylosing spondylitis and the association with other outcome measures. J Rheumatol 21:1298–1304

    PubMed  CAS  Google Scholar 

  19. Bakker C, Rutten M, van Doorslaer E, Bennet K, van der Linden S (1994) Feasibility of utility assessment by rating scale and standard gamble in patients with ankylosing spondylitis or fibromyalgia. J Rheumatol 21:269–274

    PubMed  CAS  Google Scholar 

  20. van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnosis criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 21:361–365

    Article  Google Scholar 

  21. Ariza-Ariza R, Hernández-Cruz B, Navarro-Sarabia F (2003) La versión española del BASDAI es fiable y se correlaciona con la actividad de la enfermedad en pacientes con espondilitis anquilosante. Rev Esp Reumatol 31:372–378

    Google Scholar 

  22. Jenkinson TR, Mallorie PA, Whitelock HC, Kennedy LG, Garrett SL, Calin A (1994) Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index. J Rheumatol 21:1694–1698

    PubMed  CAS  Google Scholar 

  23. The EuroQol Group (1990) EuroQol–a new facility for the measurement of health-related quality of life. Health Policy 16:199–208

    Article  Google Scholar 

  24. Badía X, Roset M, Montserrat S, Herdman M, Segura A (1999) The Spanish version of the EQ-5D: a description and its applications. European Quality of Life Scale. Med Clin (Barc) 112(suppl 1):79–85

    Google Scholar 

  25. Badía X, Roset M, Herdman M, Kind P (2001) A comparison of United Kingdom and Spanish general population time trade off values for EQ-5D health states. Med Decis Making 21:7–16

    Article  PubMed  Google Scholar 

  26. Torrance GW (1987) Utility approach to measuring health-related quality of life. J Chron Dis 40:593–600

    Article  PubMed  CAS  Google Scholar 

Download references

Disclosures

None

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rafael Ariza-Ariza.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ariza-Ariza, R., Hernández-Cruz, B., López-Antequera, G. et al. Variables related to utility in patients with ankylosing spondylitis. Clin Rheumatol 28, 207–211 (2009). https://doi.org/10.1007/s10067-008-1019-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-008-1019-5

Keywords

Navigation